News Coverage
Pearl Meister Greengard Prize News:
93-Year-Old Wins Prestigious Science Award
At 93-years-old, Brenda Milner is responsible for some of the biggest discoveries in the science of memory. And she’s still working today, at McGill University in Montreal, Canada. She’s also the winner of the prestigious Pearl Meister Greengard Prize for her achievements, which includes $100,000 in award money. (read more)
November 6, 2011
The Chronicle of Higher Education
Psychology students who read about Brenda Milner's seminal work with amnesia patients nearly 60 years ago might not suspect that she is, at 93, still engaged full time in research and teaching. Nor that last week, in New York, she would be picking up a major award, the Pearl Meister Greengard Prize, which honors female researchers who have made extraordinary contributions to the biomedical sciences. (read more)
November 3, 2011
Canadian neuroscience pioneer honoured with prestigious U.S. award
Brenda Milner is one of the most important neuroscientists of the 20th century, blazing a trail at McGill University in Montreal at a time when few women held positions of importance in science. She has received numerous awards for her work and on Thursday, at 93 years old, she’ll be honoured with another. (read more)
November 3, 2011
The Man Who Loves Women Who Love Science
Why can't all men be like Nobel Laureate Paul Greengard?
Shortly after he was awarded the 2000 Nobel Prize in Physiology or Medicine for his work on transmitters in the brain, Dr. Greengard decided to endow a scientific prize of his own -- one most of his fellow Nobel laureates could never even hope to win. (read more)
October 26, 2011
The 2011 Pearl Meister Greengard Prize: Honoring Dr. Brenda Milner for her pioneering work in cognitive neuroscience
Tragic it is when a young mother never gets to meet her newborn child; however, it is also awe-inspiring to see a victim of this circumstance rise above and honor his mother’s sacrifice. (read more)
The Scientist
 |
Philippa “Pippa” Marrack has made some unanticipated discoveries about how the immune system functions in health and disease. (read more)
May 25, 2011
Dr. Brenda Milner, a pioneer in the field of cognitive neuroscience whose discoveries revolutionized the understanding of memory, will be awarded the 2011 Pearl Meister Greengard Prize from The Rockefeller University. The prize, which carries an honorarium of $100,000, recognizes female scientists who have made exceptional contributions to biomedical science, a group that historically has not received appropriate. (read more)
May 25, 2011
2011 Pearl Meister Greengard Prize to be awarded to McGill University memory researcher
“I am absolutely delighted and amazed to receive this special award and so proud and honored to be representing women scientists in this context,” says Milner. “I am very privileged for having been able to pursue my sense of curiosity within the culture of excellence at the Montreal Neurological Institute, as well as to train and encourage talented young students — driving forces throughout my career to which I attribute much of my success. (read more)
February 7, 2011
The Matriarch of Modern Cancer Genetics: A Conversation with Janet D. Rowley
 |
Dr. Janet Davison Rowley, 85, is the matriarch of modern cancer genetics. Without her 1970s finding that broken and translocated chromosomes were a factor in blood cancers, we might not have the treatments for leukemia that are commonplace today. (read more)
October 5, 2009
3 Americans Share Nobel for Medicine
The Nobel Prize in Physiology or Medicine was awarded Monday to three American scientists who solved a problem of cell biology with deep relevance to cancer and aging. The three winners are Elizabeth H. Blackburn of the University of California, San Francisco; Carol W. Greider of the Johns Hopkins University School of Medicine; and Jack W. Szostak of Massachusetts General Hospital. (read more)
October 10, 2008
How Nobel Winners Spend Their Prize Money
 |
American neuroscientist Paul Greengard, a professor at Rockefeller University in New York City, shared the 2000 Nobel Prize in Physiology or Medicine with two other researchers for their discoveries involving the communication of nerve cells — work that paved the way for the eventual development of antidepressants, such as Prozac. Greengard invested the entire sum of his winnings, about $400,000, to establish a new award: the Pearl Meister Greengard Prize. (read more)
September 26, 2006
He Turned His Nobel Into a Prize for Women: A Conversation with Paul Greengard
When the neuroscientist Paul Greengard was named one of three winners of the 2000 Nobel Prize in Physiology or Medicine, he decided to use his award — almost $400,000 — to finance something new: the Pearl Meister Greengard Prize. (read more)
Paul Greengard News:
January 12, 2012
Imus in the Morning: New Test for Alzheimer's
FNC’s Dr. Manny Alvarez and Deirdre Imus discuss ways that the Fisher Center is developing new tests to indentify Alzheimer’s. (watch video)
August 21, 2011
Health Report: Brainiacs
Memory Serves: Paul Greengard
In 2000, Paul Greengard received a Nobel Prize for mapping the biochemical process by which nerve cells communicate. That work is being used in the development of drugs that can intervene when processes go awry and lead to psychiatric or neurological abnormalities. (read more)
July 1, 2011
Pain Relievers May Negate Action of SSRIs
Studies in mice of how NSAIDs counteract SSRIs lead to a new hypothesis that may explain why the results of treatment with both classes of medication are not always successful. (read more)
April 26, 2011
Aspirin and Prozac Can Mix Badly, Study Says
"Physicians should consider the advantages and disadvantages of giving an anti-inflammatory with the antidepressant depending on how severe the pain is and how depressed they are," said Paul Greengard, senior author on the paper and head of the molecular and cellular neuroscience lab at Rockefeller. (read more)
April 25, 2011
Drug War: How Advil May Thwart the Benefits of Prozac
"We think this effect is huge," says study author Paul Greengard, a Nobel laureate and professor of neuroscience at Rockefeller University, noting that the effect of the NSAIDs is comparable to the difference seen in clinical trials between antidepressants and placebo. "It's possible that there's a bigger effect than is apparent from these data. It could be a reason that many people are refractory to antidepressant treatment." (read more)
April 25, 2011
Popular Painkillers Can Impair Antidepressants' Effectiveness
Painkillers like Motrin may interfere with antidepressant medications, making it less likely that someone taking both will get relief from depression. (read more)
April, 25, 2011
Why Your Antidepressant May Not Be Working
In my opinion, the findings that the use of anti-inflammatory may decrease the effectiveness of many antidepressant medications, by Dr. Paul Greengard and his team are very significant, because chronic pain is often a secondary characteristic of many depressive disorders, and the use of over-the-counter anti-inflammatory drugs is quite high. (read more)
April 25, 2011
Antidepressants, OTC Painkillers Not a Good Combo
Antidepressants, known as selective serotonin reuptake inhibitors, or SSRIs, are some of the most commonly prescribed medications on the market today – and for good reason. It’s estimated that more than 20 million people in the United States suffer from depression.
For the study, Warner-Schmidt and Dr. Paul Greengard, a Nobel laureate and director of the Fisher Center for Alzheimer’s Disease Research, treated mice with antidepressants, both in the presence and absence of anti-inflammatory drugs, and then analyzed how the mice behaved in “tasks that are sensitive to antidepressant treatment.” (read more)
